The FDA is planning on imposing severe restrictions on the sale of e-cigarette products as soon as next week; marijuana was a hit with voters in the midterm election; HHS is recommending a ban on the chemicals in kratom that would make the herb as illegal as heroin or LSD.
The FDA is planning on imposing severe restrictions on the sale of e-cigarette products as soon as next week, The Washington Post reported. The ban would come as public health experts are alarmed by a huge increase in vaping among minors. The agency will also impose such rules as age-verification requirements for online sales, and it is expected to propose banning menthol in regular cigarettes.
Marijuana was a hit with voters in the midterm elections, The Hill reported. In Missouri and Utah, voters approved medical cannabis, and in Michigan, voters legalized the adult use, cultivation, and retail marketing of marijuana. In 4 states—Connecticut, Michigan, Minnesota, and Illinois—voters elected governors who openly campaigned on a platform that included legalizing adult marijuana use. In California and Colorado, voters elected governors who have spearheaded legalization reform efforts. In Maine and in New Mexico, 2 antimarijuana governors were replaced by candidates seeking cannabis reforms.
HHS is recommending a ban on the chemicals in kratom that would make the popular herbal supplement as illegal as heroin or LSD by classifying them as Schedule I substances, according to STAT News. Some scientists are worried that a ban would stifle research on chemicals that could be developed into opioid alternatives and said that banning kratom would harm people who are currently using the substance.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen